Value Investing

Joseph Hogue
September 23, 2016
Weak iPhone 7 Sales Will Mean Problems For This Telecom Giant

Preorders for the iPhone 7 are good news for some telecom companies, while they may signal bad times ahead for one industry leader.

Genia Turanova
September 23, 2016
Why I'm Buying Shares Of The 'Other' Social Network

With such a huge impact in our lives, Twitter is a company that's worth a second look

Michael Kahn
September 21, 2016
Why This Scandalized Bank Is A Contrarian's Dream

Sentiment is in the toilet after a steep drop, but the chart shows the stock setting up for a quick rebound.

Jimmy Butts
September 21, 2016
A $60 Billion Corner Of The Healthcare Sector Nobody Is Talking About

It's clear that the well-being of our pets is important, and the industry that serves them is often overlooked by the broader healthcare industry.

Michael Vodicka
September 20, 2016
This Hated Pharma Stock Has A Bright Future

This stock has taken a beating in the market recently, but investors are ignoring its true value. Details here.

Jared Levy
September 19, 2016
This Stock is Too Cheap to Pass Up

Insiders appear to see serious upside in shares, and with a number of bullish catalysts working in its favor, so do I.

Sara Nunnally
September 14, 2016
The Dirty Little Secret Goldman Doesn't Want You To Know...

While Goldman is touting financials in advance of a rate hike, it's actually buying something else. Get the details.

Brad Briggs
September 07, 2016
Fighting Global Cybercrime Will Mean Big Business

While the convenience of our daily lives has grown exponentially thanks to the advances of digital technologically, so have the potential threats against individual Americans


Genia Turanova
September 02, 2016
This Well-Known Dividend Giant Is On Sale

Many of us start our shopping trips with a sales rack and make our decisions on a case-by-case basis. Similar logic applies to the stock market: costs matter, but so do the reasons why a stock gets a discount.


Adam Fischbaum
August 30, 2016
This Pharma Company Is Leading The Race For A Zika Vaccine

I've been buying shares of a large cap, deeply discounted global pharmaceutical giant who is currently working with the U.S. Army to develop a Zika vaccine that should be ready for human trials by October of this year. You should, too.


Market Summary Chart by YCharts